Successful Portfolios LLC Buys Shares of 1,377 The Clorox Company (NYSE:CLX)

Successful Portfolios LLC bought a new stake in shares of The Clorox Company (NYSE:CLX) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 1,377 shares of the company’s stock, valued at approximately $211,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of CLX. Fortitude Family Office LLC bought a new stake in Clorox during the 4th quarter valued at $29,000. Northwest Financial Advisors purchased a new position in shares of Clorox during the 4th quarter valued at $29,000. Core Wealth Advisors Inc. purchased a new position in shares of Clorox during the 4th quarter valued at $29,000. First United Bank & Trust purchased a new position in shares of Clorox during the 4th quarter valued at $31,000. Finally, GoalVest Advisory LLC purchased a new position in shares of Clorox during the 1st quarter valued at $31,000. Institutional investors own 78.53% of the company’s stock.

Wall Street Analyst Weigh In

CLX has been the subject of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft reduced their price target on shares of Clorox from $155.00 to $151.00 and set a “hold” rating for the company in a research report on Wednesday, April 17th. Evercore ISI cut their target price on shares of Clorox from $145.00 to $142.00 and set an “underperform” rating for the company in a research report on Wednesday, May 1st. Barclays cut their target price on shares of Clorox from $136.00 to $132.00 and set an “underweight” rating for the company in a research report on Thursday, May 2nd. DA Davidson reiterated a “neutral” rating and issued a $162.00 target price on shares of Clorox in a research report on Wednesday, April 17th. Finally, UBS Group cut their target price on shares of Clorox from $164.00 to $159.00 and set a “neutral” rating for the company in a research report on Wednesday, May 1st. Five analysts have rated the stock with a sell rating and fourteen have assigned a hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $145.33.

Clorox Price Performance

CLX stock opened at $134.24 on Tuesday. The Clorox Company has a 1 year low of $114.68 and a 1 year high of $169.14. The company has a market cap of $16.67 billion, a P/E ratio of 69.55, a PEG ratio of 2.19 and a beta of 0.39. The firm has a 50-day moving average of $136.95 and a 200 day moving average of $143.79. The company has a debt-to-equity ratio of 9.73, a current ratio of 0.90 and a quick ratio of 0.53.

Clorox (NYSE:CLX) last released its quarterly earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.33 by $0.38. Clorox had a net margin of 3.33% and a return on equity of 302.49%. The company had revenue of $1.81 billion during the quarter, compared to the consensus estimate of $1.87 billion. During the same period in the prior year, the firm earned $1.51 earnings per share. Clorox’s revenue was down 5.3% on a year-over-year basis. On average, sell-side analysts forecast that The Clorox Company will post 5.91 EPS for the current year.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.